Rubric Capital Management (New York)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-28,579
Closed -$1.64M 65
2019
Q4
$1.64M Buy
+28,579
New +$1.64M 0.19% 42